Stock Events

Stock Events

Contineum Therapeutics (CTNM) Q4 2024 Earnings

Nov 6Confirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-3.55

-2.48

-1.42

-0.35

Details

Expected EPS

-0.41

Actual EPS

-0.4

Surprise EPS

0.01

Surprise Percent

+2.44%

Description

⁨Contineum Therapeutics⁩ (⁦CTNM⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.